Inventor · disambiguated record
Bindu Santhamma
Also filed as: SANTHAMMA BINDU
7 granted patents·4 pending applications·6 citations·filing 2010–2019
75Inventor score
Top patents by PatentIndex Score
11 records- 0176US10273263B2Pro-drug forming compoundsEVESTRA INC·Filed 2017·Granted Apr 30, 2019·2 cites·18 claims
- 0274US10053485B2Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agentsEVESTRA INC·Filed 2016·Granted Aug 21, 2018·2 cites·5 claims
- 0372US9745338B2Pro-drug forming compoundsEVESTRA INC·Filed 2014·Granted Aug 29, 2017·2 cites·11 claims
- 0465US10738075B2Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agentsEVESTRA INC·Filed 2018·Granted Aug 11, 2020·0 cites·9 claims
- 0553US9850273B2Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancerEVESTRA INC·Filed 2015·Granted Dec 26, 2017·0 cites·13 claims
- 0648US2020087340A1Lif/lifr antagonist in oncology and nonmalignant diseasesEVESTRA INC·Filed 2019·Application pending·0 cites
- 0746US2018155386A1Progesterone antagonistsEVESTRA INC·Filed 2017·Application pending·0 cites
- 0843US2013029953A1Progesterone antagonistsNICKISCH KLAUS·Filed 2011·Application pending·0 cites
- 0942US9096641B2Imidazolyl progesterone antagonistsNICKISCH KLAUS·Filed 2013·Granted Aug 4, 2015·0 cites·17 claims
- 1041US2013123523A1Methods for the preparation of etonogestrel and desogestrelNICKISCH KLAUS·Filed 2011·Application pending·0 cites
- 1138US8334375B2Methods for the preparation of drospirenoneNICKISCH KLAUS·Filed 2010·Granted Dec 18, 2012·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Bindu Santhamma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →